Ganoderma lucidum Polysaccharides Alleviate Diabetic Cardiomyopathy Structural Deficits and Remodeling by Attenuating Inflammatory Responses
Frontiers in Bioscience-Landmark · 15.10.2026 · 31 (10)
DOI: 10.31083/fbl54858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 15.10.2026. Verfasst von Changlin Zhen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Chongqing Three Gorges Medical College, 404120 Chongqing, China. Hauptthemen laut MEDLINE: Diabetic Cardiomyopathies, Reishi, Diabetes Mellitus, Experimental, Polysaccharides. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Chongqing, China, Special Program for High-level Talents at Chongqing Three Gorges Medical College, Science and Technology Research Program of Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Background
Diabetes is the one of the most prevalent chronic diseases worldwide and poses a serious danger to human health, following cancer and cardiovascular and cerebrovascular diseases. Diabetic cardiomyopathy (DCM) is a leading cause of death among individuals with diabetes. Ganoderma lucidum polysaccharides (GLPs) are among the principal bioactive components in the fruiting bodies of Ganoderma lucidum, and are characterized by complex structures and a range of pharmacological properties. In several studies, GLPs have been shown to exert hypoglycemic effects and to help normalize dysregulated glucose metabolism. Our team has also previously demonstrated the ability of GLPs to inhibit cardiac hypertrophy induced by increased cardiac afterload. However, systematic investigations ofthe effects of GLPs in DCM remain limited, and the molecular mechanisms through which GLPs shape DCM pathogenesis remain unclear.
Methods
We investigated the effects of Ganoderma lucidum polysaccharides (GLPs) on diabetic cardiomyopathy (DCM) in mouse models of streptozotocin-induced type 1 diabetes mellitus (T1DM) and high-fat diet-induced type 2 diabetes mellitus (T2DM).
Results
We found that GLPs exerted therapeutic effects in murine models of both T1DM and T2DM. RNA-seq analysis suggested that the anti-inflammatory of GLPs involve nuclear factor-kappa B (NF-κB) signaling. Cardiac inflammation is a key pathological process in DCM, and GLP treatment attenuated cardiac functional and structural abnormalities while reducing cardiac inflammation, fibrosis, and NF-κB signaling. GLP administration further reduced DCM-associated increases in pro-inflammatory cytokines and macrophage infiltration in T1DM and T2DM mice. In vitro, GLPs suppressed high glucose (HG)-induced cardiac hypertrophy and fibrosis, and the protective effects of GLPs were associated with NF-κB signaling.
Conclusions
Collectively, our findings demonstrate that GLPs effectively alleviate DCM and cardiac remodeling and the protective effects of GLPs are involved in NF-κB signaling. Our data suggest that GLPs may serve as a potential therapeutic agent for the treatment of DCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Basic Medical Sciences, Chongqing Three Gorges Medical College, 404120 Chongqing, China.
- Natural Drug Intervention in Aging Key Laboratory of Chongqing Education Commission of China, Chongqing Key Laboratory of Development and Utilization of Genuine Medicinal Materials in Three Gorges Reservoir Area, 404120…
- Chongqing Tangshikang Medical Technology Co., Ltd., 404120 Chongqing, China.
- School of Medical Technology, Chongqing Three Gorges Medical College, 404120 Chongqing, China.
Förderung
- Natural Science Foundation of Chongqing, China
- Special Program for High-level Talents at Chongqing Three Gorges Medical College
- Science and Technology Research Program of Chongqing Municipal Education Commission
Zitieren
APA
Zhen, C., Li, G., Chen, F., Liu, D., He, X., Miao, J., & Yan, Y. (2026). Ganoderma lucidum Polysaccharides Alleviate Diabetic Cardiomyopathy Structural Deficits and Remodeling by Attenuating Inflammatory Responses. Frontiers in Bioscience-Landmark, 31(10). https://doi.org/10.31083/fbl54858
Vancouver
Zhen C, Li G, Chen F, Liu D, He X, Miao J, et al. Ganoderma lucidum Polysaccharides Alleviate Diabetic Cardiomyopathy Structural Deficits and Remodeling by Attenuating Inflammatory Responses. Frontiers in Bioscience-Landmark. 2026;31(10). doi:10.31083/fbl54858
BibTeX
@article{Zhen2026,
author = {Zhen, Changlin and Li, Guoli and Chen, Feng and Liu, Dan and He, Xiuzhen and Miao, Jiawei and Yan, Yifan},
title = {Ganoderma lucidum Polysaccharides Alleviate Diabetic Cardiomyopathy Structural Deficits and Remodeling by Attenuating Inflammatory Responses},
journal = {Frontiers in Bioscience-Landmark},
year = {2026},
volume = {31},
number = {10},
doi = {10.31083/fbl54858}
}
EUVIMED